API | lactobacillus gasseri

lactobacillus gasseri Report issue

Cell therapy Experimental

AACT

Active Ingredient History

NOW

Lactobacillus gasseri is a species in the genus Lactobacillus identified in 1980 by François Gasser and his associates. It is part of the vaginal flora. Its genome has been sequenced. L. gasseri is a normal inhabitant of the lower reproductive tract in healthy women. It also produces Lactocillin. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

lactobacillus gasseri | lactobacillus gasseri dsm 27123 | lactobacillus gasseri ks-13

Organizations (24)

Research & Development (24)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (10)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (10)

Clostridioides difficile (Phase 3)

Clostridium Infections (Phase 1)

Diarrhea (Phase 3)

Infertility, Female (Phase 4)

Obesity (Phase 3)

Opioid-Induced Constipation (Phase 2)

Prostheses and Implants (Phase 4)

Spinal Cord Injuries (Phase 3)

Urinary Bladder, Neurogenic (Phase 3)

Vaginal Diseases (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 15
# of Trial Organizations: 24

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue